TRS4Vision - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
Public ClinicalTrials.gov record NCT05042609. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Active-Controlled, Double-Masked Study to Evaluate the Safety and Efficacy of TRS01 Eye Drops in the Treatment of Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy and safety of TRS01 eye drops compared to active comparator in subjects with active non-infectious anterior uveitis with or without uveitic glaucoma
Study identification
- NCT ID
- NCT05042609
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 0 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 20, 2021 (Actual)
- Primary completion
- Jun 29, 2023 (Actual)
- Completion
- Jun 29, 2023 (Actual)
- Last update posted
- Oct 22, 2026
2021 – 2023
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| La Jolla | La Jolla | California | 92093 | — |
| Los Angeles | Los Angeles | California | 90041 | — |
| Los Angeles 2 | Los Angeles | California | 90095-6984 | — |
| Aurora | Aurora | Colorado | 80045 | — |
| Lakewood | Lakewood | Colorado | 80228 | — |
| Jacksonville | Jacksonville | Florida | 32204 | — |
| Winter Haven | Winter Haven | Florida | 33800 | — |
| Marietta | Marietta | Georgia | 30060 | — |
| Boston | Boston | Massachusetts | 02114 | — |
| Waltham | Waltham | Massachusetts | 02451 | — |
| Washington, MO | Washington | Missouri | 63090 | — |
| Palisades Park | Palisades Park | New Jersey | 07650 | — |
| Winston-Salem | Winston-Salem | North Carolina | 27157 | — |
| Nashville | Nashville | Tennessee | 37232 | — |
| Austin | Austin | Texas | 78712 | — |
| Plano | Plano | Texas | 75075 | — |
| San Antonio 2 | San Antonio | Texas | 78238 | — |
| San Antonio | San Antonio | Texas | 78240 | — |
| Norfolk | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05042609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05042609 live on ClinicalTrials.gov.